Analysed ALTIMMUNE INC (ALT:NASDAQ) News Sources
Altimmune Shareholders Approve All AGM Proposals, Boost Authorized Shares to 400M
16-04-2026
marketbeat.com
H.C. Wainwright Bullish on Altimmune (ALT) Amid Growing Focus on Treatments for Metabolic and Liver Diseases
25-03-2026
yahoo.com
Altimmune Touts Pemvidutide Progress, Targets MASH Phase 3 Start and Q3 AUD Readout at Barclays Chat
12-03-2026
marketbeat.com
Altimmune Details Pemvidutide MASH Path: Breakthrough Therapy, FDA Feedback, Phase 3 Next Up
11-03-2026
marketbeat.com
Altimmune Details Pemvidutide Phase III MASH Plans, Breakthrough Status at Citizens Conference
10-03-2026
marketbeat.com
What is the current price of ALTIMMUNE INC (ALT:NASDAQ)?
The current price of ALTIMMUNE INC (ALT:NASDAQ) is $3.41.
ALTIMMUNE INC (ALT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALTIMMUNE INC (ALT:NASDAQ) since the previous trading day is $-0.15.
ALTIMMUNE INC (ALT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALTIMMUNE INC (ALT:NASDAQ) since the previous trading day is -4.2135%.
What is the most recent average sentiment score for ALTIMMUNE INC (ALT:NASDAQ)?
The most recent average sentiment score for ALTIMMUNE INC (ALT:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for ALTIMMUNE INC (ALT:NASDAQ)?
The most recent sentiment for ALTIMMUNE INC (ALT:NASDAQ) is .
SEC-8K** Filing Available For ALTIMMUNE INC (ALT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.